Silverstein-backed startup will test gene therapy for Parkinson’s – FierceBiotech
FierceBiotech |
Silverstein-backed startup will test gene therapy for Parkinson's
FierceBiotech Regenxbio has joined forces with investment firm OrbiMed and a new nonprofit foundation to create Prevail Therapeutics, a startup focused on new biologics and gene therapies for Parkinson's disease (PD). Prevail will draw on the expertise of the … Orbimed partner in search of a cure for Parkinson's launches new gene therapy player For Parkinson's, Two Drugs Coming And One New Co as Prevail Starts in NY The Silverstein Foundation, REGENXBIO, and OrbiMed Launch Prevail Therapeutics |
